Dr. Smitha S. Krishnamurthi, MD

Dr. Krishnamurthi practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Krishnamurthi's NPI, 1487670147, was assigned on July 15, 2006. Dr. Krishnamurthi graduated from Perelman School of Medicine - Philadelphia in 1993. Dr. Krishnamurthi holds Ohio license 35-078364.

Dr. Krishnamurthi's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Krishnamurthi's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Krishnamurthi is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Krishnamurthi to 3 more hospitals, 2 clinical labs and 1 medical group, each named with a free account. Dr. Krishnamurthi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krishnamurthi practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Krishnamurthi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Krishnamurthi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Krishnamurthi's licenses on file in 3 states: Ohio, Maryland and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer and purpura and thrombocytopenia among the conditions Dr. Krishnamurthi treats.

CMS data shows 235 Medicare services from Dr. Krishnamurthi across 4 procedure codes in 2024, all of them office visits, for 103 Medicare patients. Medicare paid $17,279 for them.

CMS counts 103 Medicare patients who saw Dr. Krishnamurthi in 2024. The largest group is 65 to 74, with 57 patients. 71% of them have cancer, and 71% have high blood pressure. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krishnamurthi's median patient age at 63, with 53% women.

In 2024, Dr. Krishnamurthi wrote 390 Medicare Part D claims for 61 patients. 71% of them were for generic drugs. CMS names the drug for 230 of them, across 12 drugs with 11 or more claims each, at $679,464 in total drug cost. In 2023, CMS named 98 claims across 5 drugs.

Dr. Krishnamurthi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krishnamurthi as offering telehealth.

Dmand AI links 110 papers to Dr. Krishnamurthi, published from 2006 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms and Colorectal Neoplasms. Dr. Krishnamurthi has published most often in J Clin Oncol. Dr. Krishnamurthi's most frequent co-authors are Suneel Deepak Kamath, Wells A. Messersmith, MD and Mary F. Mulcahy, MD.

Dmand AI links Dr. Krishnamurthi to 14 clinical trials, 6 of them phase 2 studies. Conditions studied include Rectal Neoplasms, Colonic Neoplasms and Pancreatic Neoplasms. Case Comprehensive Cancer Center sponsors the most, 5. Open Payments lists research payments to Dr. Krishnamurthi that name 1 trial.

CMS Open Payments shows 17 general payments to Dr. Krishnamurthi from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $10,850. It also lists 1 research payment totaling $110 in 2025, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Krishnamurthi, most recently America's Top Doctors in 2014.

Dr. Krishnamurthi graduated from Perelman School of Medicine - Philadelphia in 1993.

Dr. Krishnamurthi is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.